PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34535173-15	2021	UBE2S activated the Wnt/beta-catenin signaling pathway in ovarian cancer resulting in Olaparib resistance in vitro and in vivo.	olaparib	86-94	ubiquitin conjugating enzyme E2 S	Homo sapiens	0-5	
34535173-16	2021	Furthermore, UBE2S enhanced the proliferation and Olaparib resistance of ovarian cancer in its enzymatic activity dependent manner.	olaparib	50-58	ubiquitin conjugating enzyme E2 S	Homo sapiens	13-18	
34535173-0	2021	UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/beta-catenin signaling pathway.	olaparib	35-43	ubiquitin conjugating enzyme E2 S	Homo sapiens	0-5